Correlation Between Hepion Pharmaceuticals and Sarepta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Sarepta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Sarepta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Sarepta Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Sarepta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Sarepta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Sarepta Therapeutics.
Diversification Opportunities for Hepion Pharmaceuticals and Sarepta Therapeutics
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hepion and Sarepta is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Sarepta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarepta Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Sarepta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarepta Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Sarepta Therapeutics go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Sarepta Therapeutics
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 2.95 times more return on investment than Sarepta Therapeutics. However, Hepion Pharmaceuticals is 2.95 times more volatile than Sarepta Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Sarepta Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 81.00 in Hepion Pharmaceuticals on August 28, 2024 and sell it today you would lose (13.00) from holding Hepion Pharmaceuticals or give up 16.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Sarepta Therapeutics
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Sarepta Therapeutics |
Hepion Pharmaceuticals and Sarepta Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Sarepta Therapeutics
The main advantage of trading using opposite Hepion Pharmaceuticals and Sarepta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Sarepta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarepta Therapeutics will offset losses from the drop in Sarepta Therapeutics' long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Sarepta Therapeutics vs. Krystal Biotech | Sarepta Therapeutics vs. PTC Therapeutics | Sarepta Therapeutics vs. Iovance Biotherapeutics | Sarepta Therapeutics vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |